About Essenvia
Essenvia is a company based in Los Angeles (United States) founded in 2018 by Soumya Mahapatra and Basant Sahoo. Essenvia has raised $5.53 million across 3 funding rounds from investors including Benhamou Global Ventures, Pasadena Angels and Wavemaker 360. The company has 9 employees. Essenvia offers products and services including eSTAR Interface, RIM Platform, Registrations Management, Submissions Management, and Change Assessment. Essenvia operates in a competitive market with competitors including RIMSYS, ValGenesis, Sware, Virtify and 3Aware, among others.
- Headquarter Los Angeles, United States
- Employees 9
- Founders Soumya Mahapatra, Basant Sahoo
- SectorsHealthcare
- Website essenvia.com
- Social LinkedIn X
- Legal Name Essenvia Solutions Private Limited
- Date of Incorporation 27 Jan, 2021
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹4.73 Cr
FY 2025 · +26% YoY
- Net Profit₹0.54 Cr
FY 2025 · 11% margin
- EBITDA₹0.78 Cr
FY 2025 · 16% margin
- Total Equity Funding$5.53 M (USD)
in 3 rounds
- InvestorsBenhamou Global Ventures
& 5 more
- Employee Count9
Associated legal entities of Essenvia
Essenvia operates through Essenvia Solutions Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Essenvia Solutions Private Limited CIN U72900KA2021PTC143568 | Active | 27 Jan 2021 | Bangalore, Karnataka | ₹4.7 Cr | 9 | 4 | View details |
Products & Services of Essenvia
Essenvia offers a comprehensive portfolio of products and services, including eSTAR Interface, RIM Platform, Registrations Management, Submissions Management, and Change Assessment.
Facilitates collaborative authoring for FDA 510(k) submissions.
Manages workflows and ensures compliance across product lifecycles.
Handles product registration and tracking for global markets.
Automates creation and management of regulatory submissions.
Evaluates regulatory impacts of product changes.
Funding Insights of Essenvia
Essenvia has successfully raised a total of $5.53M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.5M
- Total Rounds 3
- First Round $50,000
(09 Mar 2020)
- Investors Count 6
All 3 funding rounds of Essenvia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| 15 Nov 2023 | – | Series A | – | – | – |
| 07 Mar 2023 | $5.5M | Seed | – | Wavemaker 360 , Benhamou Global Ventures | |
| 09 Mar 2020 | $50,000 | Seed | – | – |
6 investors in total: 6 institutional.
Investors in Essenvia
Essenvia has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Benhamou Global Ventures, Pasadena Angels and Wavemaker 360.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | wavemaker360.com | - | |
A specialized seed fund is operated for enterprise infrastructure startups. | – | firstraysvc.com | - | |
Early-stage venture capital firm focusing on Asia regions. | 2008 | rebrightpartners.com | - | |
Investments are facilitated by Pasadena Angels in Southern California startups. | 2000 | pasadenaangels.com | Altadena, United States | |
Venture capital firm investing in AI and cross-border enterprise startups from Silicon Valley. | 2003 | benhamouglobalventures.com | Tel Aviv, Israel | |
- | – | expertdojo.com | - |
Investor details for Essenvia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Essenvia Solutions Private Limited (Essenvia)
Essenvia Solutions Private Limited is the primary company behind Essenvia. The board of Essenvia Solutions Private Limited currently have 4 directors; the longest-serving is Basant Sahoo, appointed in 2021.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Basant Sahoo DIN 07888282 | Director | 27 Jan 2021 | 5 yrs 8 mo | Essenvia Solutions Private Limited |
| Sarojkanta Choudhury DIN 08846134 | Director | 27 Jan 2021 | 5 yrs 8 mo | Essenvia Solutions Private Limited |
| Anant Behera DIN 08348725 | Director | 27 Jan 2021 | 5 yrs 8 mo | Essenvia Solutions Private Limited |
| Soumya Mahapatra DIN 08531307 | Director | 22 Dec 2022 | 3 yrs 9 mo | Essenvia Solutions Private Limited |
People of Essenvia
9 people are tracked at Essenvia (3 in leadership, 6 in team); the tracked headcount is 9.
| Name | Role | Group |
|---|---|---|
| Co-Founder & CEO | Leadership | |
| Co-Founder | Leadership | |
Chris Shakarian | VP Marketing | Leadership |
Chetan Indolia | Machine Learning Engineer | Team |
Vinay Nagulapalli | Software Developer | Team |
Abhijit Sahu | Engineering Team Lead | Team |
Rohit Singh | Senior Software Development Engineer | Team |
Nina Zidani | Product At Essenvia | Team |
Yogesh Sati | Senior Software Engineer | Team |
Complete people profiles for Essenvia
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Essenvia
Figures of Essenvia Solutions Private Limited, the primary company behind Essenvia, for FY 2025. Revenue was ₹4.73 Cr (+26% year on year). Net profit was ₹0.54 Cr (11% margin). EBITDA was ₹0.78 Cr (16% margin).
- ₹4.73 CrRevenue · FY 2025 · +26% YoY
- ₹0.54 CrNet profit · 11% margin
- ₹0.78 CrEBITDA · 16% margin
- ₹0.01 CrPaid-up capital
- 9Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Essenvia Solutions Private Limited are on its company page.
Detailed financial statements for Essenvia
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Essenvia
3 dated milestones of Essenvia across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Essenvia is founded.
- Funding First funding round of $50K.
- Funding Latest funding round, Series A,.
Competitors of Essenvia
Essenvia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RIMSYS, ValGenesis, Sware, Virtify and 3Aware, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rimsys.io | 2017 | Pittsburgh, United States | $25.8M | 31 | Medical device regulatory management software is provided for healthcare organizations. | |
| valgenesis.com | 2005 | Fremont, United States | $24.0M | 431 | Validation software is provided for life sciences companies. | |
| sware.com | 2015 | Chelsea, United States | $24.4M | – | Validation automation platform for regulated systems is provided. | |
| virtify.com | 2004 | Cambridge, United States | $23.5M | 23 | Delivers content and compliance management software solutions. | |
| 3aware.ai | 2022 | Indianapolis, United States | $2.1M | – | Provider of real-world evidence platform for MedTech device safety and performance | |
| netregulus.com | 1999 | Boston, United States | $13.4M | – | Quality and regulatory data management solutions for life sciences industry | |
| targethealth.com | 1993 | New York, United States | – | 85 | Full-service clinical research organization software and services are provided. | |
| samarindrms.com | 1987 | Deeside, United Kingdom | – | 436 | Software solutions are provided for life sciences and other sectors. |
Detailed competitors of Essenvia
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Essenvia
Complete news archive for Essenvia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Essenvia
10 companies that operate in the same segment as Essenvia (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Essenvia
Essenvia was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Essenvia is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Soumya Mahapatra is the current CEO of Essenvia. They have also founded this company.
Essenvia is a funded company, having raised a total of $5.53M across 3 funding rounds to date. The company's 1st funding round was a Seed of $50K, raised on Mar 09, 2020.
Essenvia has 9 employees.
The primary company behind Essenvia, Essenvia Solutions Private Limited, reported revenue of ₹4.73 Cr for FY 2025, up 26% year on year.
Essenvia was founded in 2018 in Los Angeles, United States, as a provider of software solutions tailored to medical device companies. Tools are offered for managing pre- and post-market workflows, including dashboards that facilitate cross-functional collaboration, processes for handling initial and subsequent device modifications, regulatory compliance management, and administrative tasks. Operations focus on streamlining these areas for manufacturers in the healthcare sector.
Essenvia's top competitors include RIMSYS, Sware and ValGenesis.
Essenvia offers eSTAR Interface, RIM Platform, Registrations Management, Submissions Management, and Change Assessment.
Essenvia has 6 investors. Key investors include Benhamou Global Ventures, Pasadena Angels, Wavemaker 360, First Rays Venture Partners, and Rebright Partners.
Essenvia operates through Essenvia Solutions Private Limited.
The legal entities of Essenvia currently have 4 directors, including Basant Sahoo, Sarojkanta Choudhury, Anant Behera and others.